says its antitrust lawsuit is "more than a business dispute." 5 minute read January 16, 2026 at 10:19 AM Strive Specialities Inc., a major provider of compounded medicines, filed a federal lawsuit against pharmaceutical giants Eli Lilly & Co
Section S0 applies broadly to pharmacological substances that are not addressed elsewhere and have no current approval by a governmental regulatory health authority for human therapeutic use
Some providers use counterfeit or diluted product, some of these products may not even include the intended medication or may include other substances that could cause you harm
It is approved to improve blood sugar levels in adults with T2D and is taken once daily with diet and exercise
For instance, in January 2025, Nacuity Pharmaceuticals, Inc., was presented with the Fast Track designation for NPI-001 (N-acetylcysteine amide) tablets from the U.S